VET is gaining major attention following a partnership with Franklin Templeton for RWA and securing an EU MiCAR license. These moves, along with the Hayabusa protocol upgrade, fuel community discussion about VET's growing institutional adoption.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.See T&Cs.